Has James Harris received payments from drug or device companies?

Yes. Drug and device makers reported $1,108 in general payments to James Harris across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Harris did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Harris come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Harris

Medical Oncology · West Palm Beach, FLNPI 1871599951

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.

$1,108in general payments, 2019–2025

Across 66 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Seagen Inc.$162
Novartis$134
Amgen$64
Merck$62
Pharmacyclics LLC, An Abbvie Company$58
Takeda Pharmaceuticals U.S.A., Inc.$56
plus $572 from 23 others

What the payments were for

Food & beverage$1,108100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Seagen Inc.	9	$162
Novartis	8	$134
Amgen	5	$64
Merck	4	$62
Pharmacyclics LLC, An Abbvie Company	4	$58
Takeda Pharmaceuticals U.S.A., Inc.	3	$56
Astellas Pharma US Inc	3	$53
AstraZeneca	3	$50
Bristol Myers Squibb	2	$47
Pfizer	3	$41
Helsinn Therapeutics (U.S.), Inc.	2	$32
Johnson & Johnson	2	$31
Regeneron Healthcare Solutions, Inc.	2	$29
Janssen Scientific Affairs, LLC	1	$25
Jazz Pharmaceuticals Inc.	1	$22
Heron Therapeutics, Inc.	1	$22
Sanofi-aventis U.S. LLC	1	$20
Tesaro, Inc.	1	$20
Emmaus Medical, Inc.	1	$19
Gilead	1	$19
Foundation Medicine, Inc.	1	$18
Eisai Inc.	1	$18
Clovis Oncology, Inc.	1	$17
Medtronic	1	$16
Incyte Corporation	1	$16
Ipsen Biopharmaceuticals, Inc	1	$16
Genentech USA, Inc.	1	$16
E.r. Squibb & Sons, L.L.C.	1	$14
Agios Pharmaceuticals, Inc.	1	$12

How this compares

$1,108 in reported general payments places this provider in the 15th percentile of 507 medical oncology providers in Florida.

See all medical oncology providers in Florida →

Other medical oncology in West Palm Beach

Neil LoveMiami$5.6M
Mahdi TahaBoca Raton$1.7M
Raji ShameemOrlando$1.3M
Mohammad JahanzebBoca Raton$1.3M
Michel VelezOrlando$927K
Yuanbin ChenOrlando$810K
Reshma MahtaniPlantation$608K
Rebecca MorooseOrlando$543K
Yasser KhaledOrlando$444K
Judah FriedmanPalm Beach Gardens$416K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →